Cargando…
Omalizumab as a new therapeutic approach for children with severe asthma
Omalizumab has been shown to improve asthma control when added to a regimen of guideline-based therapy for inner-city children and adolescents, nearly eliminating seasonal peaks in exacerbation and reducing the need for other medications to control asthma. Below, we describe a case of a 17-year-old...
Autores principales: | Jerzyńska, Joanna, Sztafińska, Anna, Woicka-Kolejwa, Katarzyna, Stelmach, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952056/ https://www.ncbi.nlm.nih.gov/pubmed/24683398 http://dx.doi.org/10.5114/pdia.2014.40660 |
Ejemplares similares
-
Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report
por: Stelmach, Iwona, et al.
Publicado: (2014) -
Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study
por: Sztafińska, Anna, et al.
Publicado: (2017) -
Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022) -
Clinical and immunological effects of vitamin D supplementation during the pollen season in children with allergic rhinitis
por: Jerzyńska, Joanna, et al.
Publicado: (2016) -
Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
por: Stelmach, Iwona, et al.
Publicado: (2015)